2022-12-19
Casestory
A major biopharmaceutical company signed an Alfa Laval Service Agreement to prevent costly production losses after experiencing unplanned downtime of critical high-speed separators. The result?
More uptime improved operational reliability during harvesting and increased yield while ensuring patient safety.
Tags
All![pharma640](https://www.alfalaval.com/globalassets/images/local/italia/webinar/pharma640.jpg)